-
EP4100012
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4100012
| EP4100012 - DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 11.11.2022 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 13.08.2021 | Most recent event Tooltip | 26.07.2024 | Amendment by applicant | Applicant(s) | For all designated states Summit Biosciences Inc. 1513 Bull Lea Rd. Lexington, KY 40511 / US | [2022/50] | Inventor(s) | 01 /
PLUCINSKI, Gregory G. 1079 High Point Drive Nicholasville, KY 40356 / US | 02 /
RAICHE, Adrian T. 785 Lochmere Place Lexington, KY 40509 / US | 03 /
SIMS, Kristi R. 767 Flint Ridge Rd. Versailles, KY 40383 / US | [2022/50] | Representative(s) | Heller, Benjamin Henry, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2022/50] | Application number, filing date | 21750411.7 | 05.02.2021 | [2022/50] | WO2021US16873 | Priority number, date | US202062970629P | 05.02.2020 Original published format: US 202062970629 P | [2022/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021158957 | Date: | 12.08.2021 | Language: | EN | [2021/32] | Type: | A1 Application with search report | No.: | EP4100012 | Date: | 14.12.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.08.2021 takes the place of the publication of the European patent application. | [2022/50] | Search report(s) | International search report - published on: | US | 12.08.2021 | (Supplementary) European search report - dispatched on: | EP | 08.01.2024 | Classification | IPC: | A61K31/485, A61K9/00, A61K47/10, A61K47/12, A61M15/08, A61P25/36 | [2024/06] | CPC: |
A61K9/0043 (EP,US);
A61K31/485 (EP,US);
A61K47/10 (EP,US);
A61K47/12 (EP,US);
A61K9/08 (US);
A61P25/36 (EP);
|
| Former IPC [2022/50] | A61K31/485, A61K9/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/50] | Title | German: | ARZNEIMITTEL ZUR INTRANASALEN VERABREICHUNG UND DEREN VERWENDUNGEN | [2022/50] | English: | DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF | [2022/50] | French: | PRODUITS MÉDICAMENTEUX DESTINÉS À ÊTRE ADMINISTRÉS PAR VOIE INTRANASALE ET UTILISATIONS ASSOCIÉES | [2022/50] | Entry into regional phase | 01.09.2022 | National basic fee paid | 01.09.2022 | Search fee paid | 01.09.2022 | Designation fee(s) paid | 01.09.2022 | Examination fee paid | Examination procedure | 01.09.2022 | Examination requested [2022/50] | 25.07.2024 | Amendment by applicant (claims and/or description) | 25.07.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 01.09.2022 | Renewal fee patent year 03 | 27.02.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US2015174061 (WYSE JOSEPH [US], et al); | [XAI]WO2018034920 (INSYS DEV CO INC [US]); | [XAI]WO2018224674 (KLARIA PHARMA HOLDING AB [SE]); | [XAI]CA3078941 (ADAPT PHARMA OPERATIONS LTD [IE], et al) | International search | [XY]US2003004178 (CHAPLEO CHRISTOPHER BOURNE [GB], et al); | [A]US2010010031 (YUM II SU [US], et al); | [XY]US2015174061 (WYSE JOSEPH [US], et al); | [A]US2017151260 (HARIHARAN MADHU [US]); | [A]US2017304295 (CRYSTAL ROGER [US], et al); | [A]US2019269780 (LOWENTHAL RICHARD [US], et al) |